Antiviral compound protects nonhuman primates against Ebola virus

Scientists protected 75 percent of rhesus monkeys infected with Ebola virus that were treated with a compound targeting the expression of VP24, a single Ebola virus protein — suggesting that VP24 may hold the key to developing effective therapies for the deadly disease. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *